-
Mashup Score: 7Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges - Nature Reviews Clinical Oncology - 9 month(s) ago
Several trials are testing immune-checkpoint inhibitors (ICIs), alone or in combination with chemotherapy, in patients with resectable non-small-cell lung cancer as an adjuvant, neoadjuvant or perioperative approach. However, the optimal use of ICIs with curative intent in patients with early stage non-small-cell lung cancer remains unclear. The authors of this Review discuss the current trial…
Source: NatureCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 15Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer - Nature Communications - 1 year(s) ago
Plasma ctDNA is a promising method to determine patient outcome in multiple cancer types. Here, the authors use shallow WGS to create machine learning signatures to identify tumor phenotypes and predict therapy response in patients with metastatic breast cancer.
Source: NatureCategories: Latest Headlines, Oncologists2Tweet-
RT @prat_aleix: Our article @NatureComms is out! @OncoAlert https://t.co/X35Zyod9GR Yes, we can obtain much more info from liquid biopsy…
-
-
Mashup Score: 31Rational combinations of targeted cancer therapies: background, advances and challenges - Nature Reviews Drug Discovery - 1 year(s) ago
Single-agent therapies targeting specific dysregulated pathways in cancer can be highly effective, but drug resistance frequently develops. Here, Bernards and colleagues discuss the mechanisms underlying resistance to targeted therapies, and assess how these can be suppressed by using tailored combination therapies.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @NatRevDrugDisc: Rational combinations of targeted cancer therapies: background, advances and challenges https://t.co/mI4iUYRw8W A new r…
-
-
Mashup Score: 0World Cancer Research Day | - 2 year(s) ago
Event 2021 Cancer Research works: Driving Progress Against Event 2020 Let’s team up for Cancer Research One of the main challenges…
Source: www.worldcancerresearchday.comCategories: Hem/Oncs, Latest HeadlinesTweet-
📣🌟It's today! Support Cancer Research! Let's Celebrate #WorldCancerResearchDay See more 👉@WCRD24Sep https://t.co/eeZuPe1aPK https://t.co/Pzr70IlFd1
-
-
Mashup Score: 71
The increasing size of cancer datasets requires new ways of thinking for analysing and integrating these data. In this Review, Jiang et al. discuss considerations and strategies for wielding ‘big data’ ― large, information-rich datasets ― in basic research and for translational applications such as identifying biomarkers, informing clinical trials and developing new assays and treatments.
Source: NatureCategories: Latest Headlines, Oncologists2Tweet-
RT @NatureRevCancer: NEW content online! Big data in basic and translational cancer research https://t.co/X2lucO50th https://t.co/O8h6RTCpGs
-
-
Mashup Score: 3Priorities for cancer research in low- and middle-income countries – a global perspective – IARC - 2 year(s) ago
20 April 2022 In a new article, Dr Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC), and researchers from partner institutions identify five priorities for cancer research in low- and middle-income countries (LMICs), on the basis of current and projected needs. The article was published in the journal Nature Medicine. By 2030,…
Source: www.iarc.who.intCategories: Latest Headlines, Oncologists2Tweet-
RT @AndresFCardonaZ: Priorities for cancer research in low- and middle-income countries – a global perspective https://t.co/s6m5XOBLDN
-
-
Mashup Score: 11Author Center | Journal of Clinical Oncology - 2 year(s) ago
Submit to Journal of Clinical Oncology (JCO) and have your cancer research make an impact with the world’s oncologists and their patients. EZSubmit Your Article About Journal of Clinical Oncology JCO is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published thrice monthly, JCO is the foremost peer-reviewed journal focusing on…
Source: Journal of Clinical OncologyCategories: Latest Headlines, Oncologists2Tweet-
RT @JCO_ASCO: No more reformatting! Submit your manuscript format-free to @ASCO Journals with EZSubmit ✅ https://t.co/fy5M95yT1T https://t.…
-
-
Mashup Score: 15Resources for Ukrainian People with Cancer - 2 year(s) ago
To help people with cancer navigate their care during the crisis in Ukraine, ASCO has compiled resources from its patient education website Cancer.Net and the American Cancer Society. To learn more about ASCO’s response to the war in Ukraine, visit ASCO’s main website.Cancer.Net ResourcesResources in EnglishManaging Your Cancer Care During An Emergency
Source: Cancer.NetCategories: Latest Headlines, Oncologists2Tweet-
RT @jrgralow: Resources for Ukrainian People with Cancer @CancerDotNet @ASCO @acsglobal https://t.co/ly9Q29jBxg
-
-
Mashup Score: 12The PROTAC gold rush - Nature Biotechnology - 2 year(s) ago
Investment in small-molecule protein degraders is surging, but their drawbacks, limitations and risks are becoming clear.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
Protein degraders & molecular glues: promises & challenges https://t.co/sfQTyqos92 https://t.co/Z0TaewLfiu
-
RT @jsoriamd: Protein degraders & molecular glues: promises & challenges https://t.co/sfQTyqos92 https://t.co/Z0TaewLfiu
-
-
Mashup Score: 1Why Black women with ovarian cancer require greater focus - 2 year(s) ago
Providing equal access to care will not by itself equalize outcomes between Black and white women.
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @PriscilaBCMD: 🟠🟢 Why Black women with ovarian cancer require greater focus https://t.co/QyivWbLqyl by @sophiahlge 👏🏼👏🏼👏🏼 @SylvesterCanc…
-
RT @jsoriamd: Immune-checkpoint inhibition for resectable non-small-cell lung cancer : opportunities & challenges. https://t.co/CkqKHsq4bi…